Ultra Market Research | Global Asthma Drugs Market
Global Asthma Drugs Market
Report ID : 897
Category : Pharmaceuticals,Global
No Of Pages : 132
Published on: December 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Asthma Drugs Market Introduction Global Asthma Drugs Market involves the production, development, and distribution of drugs to control and treat asthma, a chronic respiratory disease that affects millions of people around the world. These drugs are available in the form of inhalers, tablets, and injectable formulations, which can help in controlling symptoms and preventing asthma attacks. Current trends indicate that there is a growing adoption of biologic therapies and combination inhalers, primarily due to increasing disease prevalence and pharmaceutical technology advancements. In 2023, the market size was valued at approximately USD 20 billion, with projections estimating a compound annual growth rate (CAGR) of 6.5% through 2030. The current scenario reveals heightened competition among manufacturers as they strive to innovate and cater to the unmet needs of diverse patient populations.
Segmentation Drug Class • Bronchodilators o Short-acting Beta-Agonists (SABAs) Albuterol Levalbuterol o Long-acting Beta-Agonists (LABAs) Formoterol Salmeterol o Others • Anti-inflammatory Drugs o Corticosteroids Inhaled Corticosteroids Systemic Corticosteroids o Leukotriene Modifiers Montelukast Zafirlukast • Others
Route of Administration • Inhalation o Metered-Dose Inhalers (MDIs) o Dry Powder Inhalers (DPIs) o Nebulizers • Oral o Tablets o Syrups • Injectable o Biologics o Others
End-User • Hospitals o Pediatric Wards o Emergency Units • Homecare o Personal Inhaler Users o Maintenance Therapy Users • Specialty Clinics o Pulmonology Clinics o Allergy Clinics
Drivers Global Asthma Drugs Market is driven by several factors. The increase in prevalence due to urbanization and environmental pollution has increased demand for effective treatment. Developments in drug delivery systems such as smart inhalers and biologics serve patients with their specific requirements, thus making them adhere more to treatment plans. Initiatives undertaken by public and private sectors to make the public aware of the proper management of asthma drive the market further. Furthermore, increasing healthcare expenditure, especially in emerging economies, enhances access to advanced asthma medications. These factors collectively foster the market's growth trajectory.
Restraints Despite its growth potential, the Global Asthma Drugs Market faces challenges. High treatment costs, particularly for biologics and advanced inhalers, restrict access in low-income regions. The regulatory environment, requiring extensive clinical trials, delays product launches. Additionally, patient non-compliance due to inadequate awareness and fear of medication side effects hampers treatment efficacy. Generic drug competition further pressures pricing strategies, impacting revenue streams for leading manufacturers.
Opportunity Opportunities exist in the Global Asthma Drugs Market with respect to the growing investment for research and development of novel therapies. The trend of telemedicine and digital health platforms encourages remote monitoring and management of asthma, thereby increasing demand for connected devices. The emerging market of Asia-Pacific is currently an unexplored domain because of rising income levels and awareness programs. There are also new avenues open with precision medicine and the study of biomarkers, making targeted therapies available for these patients suffering from asthma.
Trend Major trend in the Global Asthma Drugs Market is the convergence of digital technology with asthma management. Smart inhalers with sensors monitor usage and provide real-time feedback to patients and healthcare providers. Biologics targeting specific inflammatory pathways are increasingly being adopted, offering hope for severe asthma patients. Companies are also focusing on eco-friendly inhalers, addressing environmental concerns about propellants in traditional devices. This combination of technology and sustainability defines the market's evolution.
Key Target Audience • Healthcare Providers • Pharmaceutical Companies • Research Institutes • Regulatory Authorities • Patients and Patient Advocacy Groups
Frequently Asked Questions (FAQ's)
The market size is approximately USD 20 billion as of 2023.
Anti-inflammatory drugs, particularly inhaled corticosteroids, dominate the market.
Rising prevalence of asthma, advancements in biologics, and increased awareness initiatives.
Asia-Pacific is expected to witness the fastest growth due to improving healthcare infrastructure.
Manufacturers are developing eco-friendly inhalers to reduce carbon footprint.
1. Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
2. Market Dashboard
3. Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Drug Class 3.2.1.1 Bronchodilators Short-acting Beta-Agonists (SABAs) Long-acting Beta-Agonists (LABAs) 3.2.1.2 Anti-inflammatory Drugs Corticosteroids Leukotriene Modifiers 3.2.1.3 Others 3.2.2 By Route of Administration Inhalation (MDIs, DPIs, Nebulizers) Oral (Tablets, Syrups) Injectable (Biologics, Others) 3.2.3 By End-User Hospitals (Emergency Units, Pediatric Wards) Homecare Specialty Clinics (Pulmonology, Allergy Clinics) 3.2.4 By Distribution Channel Hospital Pharmacies Retail Pharmacies (Chain, Standalone) Online Pharmacies 3.2.5 By Geography North America, Europe, Asia-Pacific, Latin America, MEA 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges
4. Global Asthma Drugs Market by Drug Class 4.1 Introduction 4.2 Market Size and Growth Rate by Drug Class (2024–2030) 4.2.1 Bronchodilators (SABAs, LABAs, Others) 4.2.2 Anti-inflammatory Drugs (Corticosteroids, Leukotriene Modifiers) 4.2.3 Others
5. Global Asthma Drugs Market by Route of Administration 5.1 Introduction 5.2 Market Size and Growth Rate by Route of Administration (2024–2030) 5.2.1 Inhalation (MDIs, DPIs, Nebulizers) 5.2.2 Oral (Tablets, Syrups) 5.2.3 Injectable (Biologics, Others)
6. Global Asthma Drugs Market by End-User 6.1 Introduction 6.2 Market Size and Growth Rate by End-User (2024–2030) 6.2.1 Hospitals (Emergency Units, Pediatric Wards) 6.2.2 Homecare 6.2.3 Specialty Clinics (Pulmonology, Allergy Clinics)
7. Global Asthma Drugs Market by Distribution Channel 7.1 Introduction 7.2 Market Size and Growth Rate by Distribution Channel (2024–2030) 7.2.1 Hospital Pharmacies 7.2.2 Retail Pharmacies (Chain, Standalone) 7.2.3 Online Pharmacies
8. Global Asthma Drugs Market by Geography 8.1 Introduction 8.2 Market Size and Growth Rate by Region (2024–2030) 8.2.1 North America (United States, Canada) 8.2.2 Europe (Germany, France, United Kingdom, Rest of Europe) 8.2.3 Asia Pacific (China, Japan, India, Southeast Asia, Rest of APAC) 8.2.4 Latin America (Brazil, Rest of LATAM) 8.2.5 Middle East & Africa (GCC, North Africa, South Africa, Rest of MEA)
10. List of Tables and Figures • Table 1: Global Asthma Drugs Market Size by Drug Class (2024–2030) • Table 2: Regional Market Sizes and Growth Rates • Figure 1: Asthma Drug Market Segmentation by Geography • Figure 2: Market Share of Top Players
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global Asthma Drugs Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Asthma Drugs Market for the past year and forecasts for the next six years. Global Asthma Drugs Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global Asthma Drugs Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global Asthma Drugs Market from different application industries in different regions.
Segmentation Drug Class • Bronchodilators o Short-acting Beta-Agonists (SABAs) Albuterol Levalbuterol o Long-acting Beta-Agonists (LABAs) Formoterol Salmeterol o Others • Anti-inflammatory Drugs o Corticosteroids Inhaled Corticosteroids Systemic Corticosteroids o Leukotriene Modifiers Montelukast Zafirlukast • Others
Route of Administration • Inhalation o Metered-Dose Inhalers (MDIs) o Dry Powder Inhalers (DPIs) o Nebulizers • Oral o Tablets o Syrups • Injectable o Biologics o Others
End-User • Hospitals o Pediatric Wards o Emergency Units • Homecare o Personal Inhaler Users o Maintenance Therapy Users • Specialty Clinics o Pulmonology Clinics o Allergy Clinics
